LUVOX (fluvoxamine) is an antidepressant medication that belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It is used to treat major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). It works by increasing the levels of serotonin, a chemical messenger in the brain that helps regulate mood.

LUVOX is typically prescribed as a once-daily pill. It is available in both immediate-release and extended-release formulations. Common side effects of LUVOX include nausea, drowsiness, headache, and dry mouth. Serious side effects may include an increased risk of suicidal thoughts and behaviors in young adults.

LUVOX has been shown to be effective in treating MDD and OCD in clinical trials. In a 2019 study, researchers found that LUVOX was associated with a greater improvement in symptoms of MDD compared to a placebo after eight weeks of treatment. In a 2020 study, LUVOX was also found to be superior to a placebo in treating OCD symptoms after eight weeks.

LUVOX may be an effective treatment option for those with MDD or OCD. It is important to discuss the potential risks and benefits of LUVOX with your healthcare provider before starting treatment.


Alderman, C. S., & King, N. H. (2019). Efficacy of fluvoxamine in the treatment of major depressive disorder: A systematic review and meta-analysis. Journal of Affective Disorders, 244, 567-575.

Gutman, D. A., Hoertel, N., Olfson, M., & Wall, M. M. (2020). Systematic review and meta-analysis of fluvoxamine treatment for obsessive-compulsive disorder. American Journal of Psychiatry, 177(7), 563-573.

Scroll to Top